An Active Presence on Capitol Hill
Recognizing the need for more research into causes and treatments of functional gastrointestinal and motility disorders,IFFGD has provided oral and/or written testimony to Congressional subcommittees many times over the years.
Each fiscal year (FY), Congress decides how much funding to provide federally supported medical research initiatives, what areas of research should be prioritized, and how much funding should be committed towards new drug approval and the monitoring of current treatment options.Whenever appropriate, IFFGD offers testimony which expresses the needs of functional GI and motility disorder patients and urges additional resources for the National Institutes of Health (NIH) and Food & Drug Administration (FDA).
IFFGD has presented the needs of the digestive health community to both the Senate and the House Appropriations Subcommittees on Labor, Health & Human Services, Education and Related Agencies, as well as the Senate Appropriations Subcommittee on Defense.
April 29, 2015
IFFGD submitted written testimony to the House Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies regarding Fiscal Year 2016 appropriations for the National Institutes of Health (NIH). Read the full testimony here.
June 6, 2012
IFFGD provided oral testimony regarding Fiscal Year 2013 appropriations for the Department of Defense (DOD) Gulf War Illness Research Program to the U.S Senate Appropriations Committee, Subcommittee On Defense. Read the full testimony here.
June 22, 2011
IFFGD presented oral testimony regarding Fiscal Year 2012 appropriations for the Department of Defense (DOD) Peer Reviewed Medical Research Program to the U.S. Senate Appropriations Committee, Subcommittee On Defense. View video or read the full testimony here.
May 1, 2009
IFFGD submitted written testimony to the House Committee on Appropriations; Subcommittee on Labor, Health and Human Services, Education and Related Agencies regarding Fiscal Year 2010 appropriations for the National Institutes of Health. Read the full testimony here.
April 28, 2008
IFFGD provided written testimony regarding Fiscal Year 2009 appropriations for the National Institutes of Health to the Senate Committee on Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies. Read the full testimony here.
March 27, 2007
IFFGD provided oral testimony regarding Fiscal Year 2008 Funding for Functional Gastrointestinal and Motility Disorders Research before the House Appropriations Subcommittee on Labor, Health & Human Services, Education and Related Agencies. Read the full testimony here.
May 19, 2006
IFFGD presented oral testimony to both the U.S. Senate and U.S. House Appropriations Subcommittees on Labor, Health & Human Services, Education and Related Agencies regarding Fiscal Year 2007 Funding for Functional Gastrointestinal and Motility Disorders Research. Read the full testimony here.
2005
IFFGD provided oral testimony before the House Appropriations Subcommittee on Labor, Health & Human Services, Education and Related Agencies regarding Fiscal Year 2006 Funding for Functional Gastrointestinal and Motility Disorders Research. Read the full testimony here.
2004
IFFGD presented oral testimony regarding Fiscal Year 2005 Funding for Functional Gastrointestinal and Motility Disorders Research before the House Appropriations subcommittee on Labor, Health & Human Services, Education and Related Agencies. Read the full testimony here.
May 7, 2003
IFFGD provided oral testimony before the House Appropriations Subcommittee on Labor, Health & Human Services, Education and Related Agencies regarding Fiscal Year 2004 Funding for Functional Gastrointestinal and Motility Disorders Research. Read the full testimony here.
May 2, 2002
IFFGD presented oral testimony regarding Fiscal Year 2003 Irritable Bowel Syndrome Research to the House Appropriations Subcommittee on Labor, Health & Human Services, Education and Related Agencies. Read the full testimony here.
